Update: BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200

MT Newswires Live06-17 22:15

(Updates to include BofA's commentary)

BofA Securities Downgrades Leidos (LDOS) to neutral from buy, which reflects increasing pressure across what was once a blooming healthcare portfolio.

The value of the company's defense portfolio and its strong alignment with DoW's priorities, including small cruise missiles, C2, counter UAS, hypersonics, and unmanned maritime solutions are still recognized but investors are unlikely to give credit for full value of the opportunities until the results begin to materialize, analysts led by Mariana Perez Mora wrote in a Wednesday note.

Additionally, there are "no meaningful signs" of an accelerated sustained growth, the analysts mentioned.

The analysts also cut Leidos' price target to $125 from $200.

Leidos has an average rating of overweight and mean price target of $174.93, according to analysts polled by FactSet.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 110.30, Change: -3.29, Percent Change: -2.89

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2644674491?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 22:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644674491","market":"fut","top_or_hot":-1,"title":"Update: BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200","media":"MT Newswires Live","content":"<html><body><p> (Updates to include BofA's commentary)</p><p>BofA Securities Downgrades Leidos (LDOS) to neutral from buy, which reflects increasing pressure across what was once a blooming healthcare portfolio.</p><p>The value of the company's defense portfolio and its strong alignment with DoW's priorities, including small cruise missiles, C2, counter UAS, hypersonics, and unmanned maritime solutions are still recognized but investors are unlikely to give credit for full value of the opportunities until the results begin to materialize, analysts led by Mariana Perez Mora wrote in a Wednesday note.</p><p>Additionally, there are \"no meaningful signs\" of an accelerated sustained growth, the analysts mentioned.</p><p>The analysts also cut Leidos' price target to $125 from $200.</p><p>Leidos has an average rating of overweight and mean price target of $174.93, according to analysts polled by FactSet.</p><p>(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)</p><p>Price: 110.30, Change: -3.29, Percent Change: -2.89</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Update: BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUpdate: BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-17 22:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> (Updates to include BofA's commentary)</p><p>BofA Securities Downgrades Leidos (LDOS) to neutral from buy, which reflects increasing pressure across what was once a blooming healthcare portfolio.</p><p>The value of the company's defense portfolio and its strong alignment with DoW's priorities, including small cruise missiles, C2, counter UAS, hypersonics, and unmanned maritime solutions are still recognized but investors are unlikely to give credit for full value of the opportunities until the results begin to materialize, analysts led by Mariana Perez Mora wrote in a Wednesday note.</p><p>Additionally, there are \"no meaningful signs\" of an accelerated sustained growth, the analysts mentioned.</p><p>The analysts also cut Leidos' price target to $125 from $200.</p><p>Leidos has an average rating of overweight and mean price target of $174.93, according to analysts polled by FactSet.</p><p>(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)</p><p>Price: 110.30, Change: -3.29, Percent Change: -2.89</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LDOS","symbol_name":"Leidos Holdings Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2644674491","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644674491","pubTimestamp":1781705728,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"(Updates to include BofA's commentary)BofA Securities Downgrades Leidos (LDOS) to neutral from buy, which reflects increasing pressure across what was once a blooming healthcare portfolio.The value of","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"LDOS":"Leidos Holdings Inc"},"translate_title":"更新：美国银行证券将Leidos评级从买入下调至中性，目标价从200美元下调至125美元","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LDOS":1.5},"content_text":"(Updates to include BofA's commentary)BofA Securities Downgrades Leidos (LDOS) to neutral from buy, which reflects increasing pressure across what was once a blooming healthcare portfolio.The value of the company's defense portfolio and its strong alignment with DoW's priorities, including small cruise missiles, C2, counter UAS, hypersonics, and unmanned maritime solutions are still recognized but investors are unlikely to give credit for full value of the opportunities until the results begin to materialize, analysts led by Mariana Perez Mora wrote in a Wednesday note.Additionally, there are \"no meaningful signs\" of an accelerated sustained growth, the analysts mentioned.The analysts also cut Leidos' price target to $125 from $200.Leidos has an average rating of overweight and mean price target of $174.93, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)Price: 110.30, Change: -3.29, Percent Change: -2.89","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644674491","isCrawlerRequest":true}